Decellularised Extracellular Carpets for the Innovative Production of Human Engineered Replicates

This project aims to accelerate the development of cell-derived products using macromolecular crowding, enhancing European biotech competitiveness and creating new jobs and markets.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

The major roadblock in the commercialization of cell-derived products is the prolonged ex vivo culture period required to develop them.

Macromolecular Crowding

Macromolecular crowding (MMC), a biophysical phenomenon that increases the kinetics of biochemical reactions and biological processes by several orders of magnitude, allows for the accelerated development of cell-derived products.

Project Objectives

This project will exploit MMC in the development of cell-derived products through:

  1. Two technical work-packages
  2. Three commercial work-packages

These efforts aim to increase the international competitiveness of European-based biotech industries and create new employment, markets, and revenue.

Project Duration and Training

This 18-month interdisciplinary and intersectoral project will train one post-doctoral researcher at the forefront of scientific research and technological innovation.

Location

The project will be carried out at University College Dublin, Ireland’s largest university, which is one of Europe’s leading research-intensive universities and in the top 1% of universities worldwide.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-1-2024
Einddatum30-6-2025
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINpenvoerder

Land(en)

Ireland

Vergelijkbare projecten binnen European Research Council

ERC Proof of...

Commercial feasibility of a cell-free reactor setup for optimisation of complex enzymatic pathways

This project aims to commercialize a continuous stirred tank reactor for optimizing complex enzymatic pathways, enhancing production efficiency and establishing a viable commercialization strategy.

€ 150.000
ERC Proof of...

Advanced 3D in vitro models based on magnetically-driven docking of modular microscaffolds

This project aims to develop 3D modular co-culture systems using magnetic microscaffolds to replicate brain tumor microenvironments for drug screening and cancer therapy testing.

€ 150.000
ERC Proof of...

Scaling up iPSC Expansion and Differentiation using Recombinant Bioemulsions

The project aims to develop scalable, regulatory-compliant bioemulsions using engineered protein nanosheets for efficient iPSC culture and differentiation, enhancing cell manufacturing and biotech market growth.

€ 150.000
ERC Proof of...

High Throughput Modelling and Measurement of Human Epithelial Models using Electrospun Conducting Polymers For Unlocking Data-Driven Drug Discovery

The project aims to enhance drug discovery by developing simplified Organ on Chip platforms through hydrogel electrospinning, enabling scalable monitoring and integration into industry workflows.

€ 150.000
ERC Advanced...

Continuous Digitalized Processes for Producing Biopharmaceuticals

Developing a Digital Twin-based methodology for continuous, integrated biopharmaceutical production to enhance efficiency and support advanced therapies like mRNA vaccines and personalized medicine.

€ 2.500.000

Vergelijkbare projecten uit andere regelingen

EIC Transition

Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based scaffold bioreactor

The project aims to upscale ex vivo production of universal platelets using innovative technologies to meet rising demand and ensure compatibility for patients with transfusion reactions.

€ 1.798.152
Mkb-innovati...

Humane mini-breinen voor R&D-toepassingen

Het project ontwikkelt een applicatie voor het kweken en analyseren van humane mini-breinen, ter vermindering van dierproeven.

€ 744.000
EIC Transition

Prefabricated Mature Blood Vessels and Tools for Vascularized 3D Cell Culture

The Vasc-on-Demand project aims to develop three innovative products for easy generation of vascularized 3D tissues, enhancing research and drug testing while reducing reliance on animal trials.

€ 2.488.750
EIC Transition

Bringing 3D cardiac tissues to high throughput for drug discovery screens

Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.

€ 1.457.500
EIC Pathfinder

AI-powered platform for autologous iPSC manufacturing

The project aims to develop an AI-guided microfluidic device for the standardized, cost-effective mass production of personalized iPSCs to enhance cancer therapies and tissue regeneration.

€ 3.999.225